The company’s exports increased 6.3% in the first half, to RON72 million. The main export markets were Asia (35%), North America (20%) and Europe (15%).
The company plans to invest RON92 million this year in enhancing and upgrading production capabilities.
Antibiotice Iasi ranks third among pharmaceutical producers in Romania by 2018 turnover, after Terapia and Zentiva. Antibiotice had a turnover of RON365 million in 2018, up 8% on the year.